These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14691922)

  • 1. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
    Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
    Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone.
    Murakami I; Gogusev J; Fournet JC; Glorion C; Jaubert F
    Hum Pathol; 2002 May; 33(5):555-60. PubMed ID: 12094383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality.
    Yousem SA; Colby TV; Chen YY; Chen WG; Weiss LM
    Am J Surg Pathol; 2001 May; 25(5):630-6. PubMed ID: 11342775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis.
    Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R
    Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome.
    Nodit L; McGrath KM; Zahid M; Jani N; Schoedel KE; Ohori NP; Carty S; Finkelstein S; Khalid A
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1474-8. PubMed ID: 16996803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
    Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
    Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
    Dacic S; Finkelstein SD; Yousem SA
    Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of allelic loss of synchronous adenocarcinomas of the lung.
    Dacic S; Ionescu DN; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Jul; 29(7):897-902. PubMed ID: 15958854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
    Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ
    Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss analysis of early-stage flat-type colorectal tumors.
    Orita H; Sakamoto N; Ajioka Y; Terai T; Hino O; Sato N; Shimoda T; Kamano T; Tsurumaru M; Fujii H
    Ann Oncol; 2006 Jan; 17(1):43-9. PubMed ID: 16249214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
    Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
    Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
    Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck.
    Domfeh AB; Fichera M; Hunt JL
    Arch Pathol Lab Med; 2006 Aug; 130(8):1184-7. PubMed ID: 16879020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of primary and recurrent giant cell tumors of bone.
    Rao UN; Goodman M; Chung WW; Swalski P; Pal R; Finkelstein S
    Cancer Genet Cytogenet; 2005 Apr; 158(2):126-36. PubMed ID: 15796959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.